Pacira Biosciences, Inc. (PCRX)
24.96
+0.10
(+0.40%)
USD |
NASDAQ |
Aug 25, 11:32
Pacira Biosciences Max Drawdown (5Y) : 85.67% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 85.67% |
| June 30, 2026 | 85.67% |
| May 31, 2026 | 85.67% |
| April 30, 2026 | 85.67% |
| March 31, 2026 | 85.67% |
| February 28, 2026 | 85.67% |
| January 31, 2026 | 85.67% |
| December 31, 2025 | 85.67% |
| November 30, 2025 | 85.67% |
| October 31, 2025 | 85.67% |
| September 30, 2025 | 85.67% |
| August 31, 2025 | 85.67% |
| July 31, 2025 | 85.67% |
| June 30, 2025 | 85.67% |
| May 31, 2025 | 85.67% |
| April 30, 2025 | 85.67% |
| March 31, 2025 | 85.67% |
| February 28, 2025 | 85.67% |
| January 31, 2025 | 85.67% |
| December 31, 2024 | 85.67% |
| November 30, 2024 | 85.67% |
| October 31, 2024 | 85.67% |
| September 30, 2024 | 85.67% |
| August 31, 2024 | 85.67% |
| July 31, 2024 | 76.27% |
| Date | Value |
|---|---|
| June 30, 2024 | 70.10% |
| May 31, 2024 | 70.10% |
| April 30, 2024 | 70.10% |
| March 31, 2024 | 70.10% |
| February 29, 2024 | 70.10% |
| January 31, 2024 | 70.10% |
| December 31, 2023 | 70.10% |
| November 30, 2023 | 70.10% |
| October 31, 2023 | 70.10% |
| September 30, 2023 | 70.10% |
| August 31, 2023 | 70.10% |
| July 31, 2023 | 70.10% |
| June 30, 2023 | 72.46% |
| May 31, 2023 | 74.39% |
| April 30, 2023 | 74.39% |
| March 31, 2023 | 76.94% |
| February 28, 2023 | 76.94% |
| January 31, 2023 | 76.94% |
| December 31, 2022 | 76.94% |
| November 30, 2022 | 76.94% |
| October 31, 2022 | 76.94% |
| September 30, 2022 | 76.94% |
| August 31, 2022 | 76.94% |
| July 31, 2022 | 76.94% |
| June 30, 2022 | 76.94% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Zimmer Biomet Holdings, Inc. | 51.64% |
| Liquidia Corp. | 93.87% |
| Johnson & Johnson | 18.44% |
| Merck & Co., Inc. | 43.45% |
| ANI Pharmaceuticals, Inc. | 72.96% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -20.94 |
| Beta (5Y) | 0.2665 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 41.48% |
| Historical Sharpe Ratio (5Y) | -0.4458 |
| Historical Sortino (5Y) | -0.6804 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.18% |